Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.

Finasteride may help treat recurrent priapism in children, but more research is needed.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Man experienced sexual dysfunction, depression, breast growth, and skin discoloration after taking finasteride for hair loss.

These medications for BPH have known risks and may have new side effects.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Premature hair whitening or loss may indicate a risk for erectile dysfunction.

DHT deficiency increases iNOS expression in rat testis and epididymis.

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

A patient developed a blister at the injection site after hepatitis C treatment.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.